News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Lecia Sequist highlights the established importance of biomarker testing to tailor appropriate treatment
Photo of Lecia Sequist from X
Dec 11, 2024, 14:33

Lecia Sequist highlights the established importance of biomarker testing to tailor appropriate treatment

Coral Olazagasti shared on X:

“Look how far we’ve come 

Lecia Sequist presents all the approved agents for NSCLC
This continues to highlight the established importance of biomarker testing to tailor appropriate treatment. “
Lecia Sequist highlights the established importance of biomarker testing to tailor appropriate treatment

Coral Olazagasti, MD is an assistant professor at the Sylvester Cancer Center, University of Miami at Miami. Being a Latina physician, she is personally invested in ethnic and racial disparities in the medical field. She earned her MD from the Universidad Central del Caribe, Puerto Rico.

More posts featuring Coral Olazagasti. 

cancer Coral Olazagasti Lecia Sequist OncoDaily Oncology
Special Coverage
Insight
Dec 11, 2024, 14:59
Immunovia Announced Major Milestone in Early-Stage Pancreatic Cancer Detection
Insight
Dec 11, 2024, 14:53
Five articles suggested by Yan Leyfman
Blog
Dec 11, 2024, 14:33
Sabrina Hanna: Visiting Kite Pharma's CAR T-Cell Manufacturing Facility
Blog
Dec 11, 2024, 14:33
The importance of science and artistry in Radiotherapy planning in NPC
Blog
Dec 11, 2024, 14:33
Samer Al Hadidi: Oral Myeloma - Majestec-4/EMN30 presented at ASH24
Insight
Dec 11, 2024, 14:33
What to Expect From a Low-Nicotine Product Standard for Cigarettes
Blog
Dec 11, 2024, 14:33
The role of ABO matching in stem cell transplant
Blog
Dec 11, 2024, 14:33
Aakash Desai: The next frontier in immunotherapy Oral immune checkpoint inhibitors
Blog
Dec 11, 2024, 14:33
Sanjay Popat: Becotarug and osimertinib cohort expansion in treatment-naive EGFR mutation
Blog
Dec 11, 2024, 14:33
Talha Badar: The outcome of TP53m MDS with HMA and VEN vs HMA alone at ASH24
Blog
Dec 11, 2024, 14:33
Lecia Sequist highlights the established importance of biomarker testing to tailor appropriate treatment
Blog
Dec 11, 2024, 13:22
Yvonne Diaz: Bryant Lin sharing his story about his EGFR Lung Cancer diagnosis